PDLI Financial Facts

License and other: -193K
Interest and other expense: -4.55M
See Full Income Statement

Total stockholders' deficit: 742.53M
Other long-term liabilities: 53.06M
See Full Balance Sheet

PDL BioPharma, Inc. (PDLI) Earnings

  |   Expand Research on PDLI
Next EPS Date 8/5/16 *Est. EPS Growth Rate +4.0% *Last Qtr.
Average EPS % Beat Rate -5.9% Revenue Growth Rate -30.9% *Last Qtr.
Average % Move 1-Wk after EPS -3.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/4/16 Q116 $0.52$0.50 +$0.02$103.4M$142.05M N/A Details
2/22/16 Q415 $0.61$0.54 +$0.07$178.1M$149.2M N/A Details
11/4/15 Q315 $0.42$0.61 -$0.19$124.6M$164.8M N/A Details
8/5/15 Q215 $0.47$0.52 -$0.05$138.1M$137.75M N/A Details
5/6/15 Q115 $0.50$0.52 -$0.02$149.7M$140.8M N/A Details
2/23/15 Q414 $0.32$0.57 -$0.25$117.1M$158.15M N/A Details
11/10/14 Q314 $0.61$0.56 +$0.05$164.6M$165.1M N/A Details
8/18/14 Q214 $0.52$0.46 +$0.06$162.8M$134.07M N/A Details